Abstract
Childhood rashes or exanthemas are common and are usually relatively
benign. There are many causes of rash in children, including mainly
viruses, and less often bacterial toxins, drugs, allergens, and other
diseases. Viral exanthema often appears while children are taking a
medication in the course of a viral infection; it can mimic drug
exanthema, and is perceived as a drug allergy in 10% of cases. The
drugs most commonly implicated are beta-lactams (BL) and nonsteroidal
anti-inflammatory drugs (NSAIDs). Viruses, commonly Epstein Barr virus
(EBV), human herpesvirus 6 (HHV6) and cytomegalovirus (CMV), and the
bacterium Mycoplasma pneumoniae, may cause exanthema either from the
infection itself (active or latent) or because of interaction with drugs
that are taken simultaneously. Determination of the exact diagnosis
requires a careful clinical history and thorough physical examination.
Haematological and biochemical investigations and histology are not
always helpful in differentiating between the two types of exanthema.
Serology or polymerase chain reaction (PCR) can be helpful, although a
concomitant acute infection does not exclude drug hypersensitivity. A
drug provocation test (DPT), although considered the gold standard for
the diagnosis, is not preferred by the patients. Skin tests are not well
tolerated, and in vitro tests, such as the basophil activation test and
lymphocyte transformation, are of low sensitivity and specificity and
their relevance is debatable. Based on current evidence, we propose a
systematic clinical approach for timely differential diagnosis and
management of rashes in children who present a cutaneous eruption while
receiving a drug.